IRIS Institutional Research Information System - OPENBS Open Archive UniBS

DE PETRO, Giuseppina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.506
EU - Europa 6.013
AS - Asia 4.986
SA - Sud America 1.011
AF - Africa 95
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 22
AN - Antartide 1
Totale 19.657
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.329
CN - Cina 1.780
SG - Singapore 1.612
PL - Polonia 1.486
DE - Germania 1.143
UA - Ucraina 951
BR - Brasile 855
IT - Italia 731
HK - Hong Kong 479
FI - Finlandia 375
GB - Regno Unito 307
VN - Vietnam 296
RU - Federazione Russa 274
IN - India 266
FR - Francia 257
TR - Turchia 201
IE - Irlanda 156
CA - Canada 102
SE - Svezia 102
ID - Indonesia 69
AR - Argentina 61
BD - Bangladesh 57
MX - Messico 55
BE - Belgio 52
IQ - Iraq 35
ZA - Sudafrica 34
AT - Austria 33
EC - Ecuador 32
ES - Italia 31
NL - Olanda 30
JP - Giappone 28
PK - Pakistan 23
EU - Europa 21
AU - Australia 20
RO - Romania 20
KR - Corea 18
PY - Paraguay 15
IR - Iran 14
SA - Arabia Saudita 14
CO - Colombia 13
KE - Kenya 12
MA - Marocco 12
AE - Emirati Arabi Uniti 11
CH - Svizzera 11
CZ - Repubblica Ceca 11
AZ - Azerbaigian 9
CL - Cile 9
UZ - Uzbekistan 9
LT - Lituania 8
IL - Israele 7
MU - Mauritius 7
OM - Oman 7
PE - Perù 7
SD - Sudan 7
TH - Thailandia 7
VE - Venezuela 7
JO - Giordania 6
UY - Uruguay 6
BO - Bolivia 5
EG - Egitto 5
JM - Giamaica 5
KZ - Kazakistan 5
LY - Libia 5
TN - Tunisia 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
MY - Malesia 4
RS - Serbia 4
TW - Taiwan 4
BG - Bulgaria 3
DK - Danimarca 3
EE - Estonia 3
GR - Grecia 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AM - Armenia 2
BH - Bahrain 2
BY - Bielorussia 2
GE - Georgia 2
HN - Honduras 2
KG - Kirghizistan 2
LB - Libano 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
TM - Turkmenistan 2
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
CG - Congo 1
Totale 19.646
Salva come PNG Salva come JPEG
Città #
Warsaw 1.483
Singapore 735
Jacksonville 673
Fairfield 605
Ashburn 567
Hong Kong 470
Woodbridge 469
Chandler 465
Beijing 421
Ann Arbor 391
Houston 317
Wilmington 294
Princeton 288
Nanjing 266
Cambridge 263
Seattle 238
New York 235
Brescia 221
Helsinki 206
Los Angeles 191
Dublin 155
Dearborn 151
Istanbul 149
Des Moines 110
Munich 107
Buffalo 102
Ho Chi Minh City 99
Nanchang 91
The Dalles 91
Chicago 84
Moscow 76
Shenyang 72
São Paulo 72
Dong Ket 70
Milan 70
Jinan 68
Hebei 67
Dallas 66
Changsha 59
San Francisco 59
Shanghai 57
Redondo Beach 52
Tianjin 52
Brussels 49
Jiaxing 49
Jakarta 47
Lancaster 47
Kunming 41
Pune 35
Turku 35
Hanoi 34
Rio de Janeiro 33
Toronto 33
Santa Clara 31
Brooklyn 30
San Diego 30
Hangzhou 28
London 26
Salt Lake City 26
Guangzhou 25
Kocaeli 25
Verona 25
Zhengzhou 25
Lappeenranta 24
Johannesburg 22
Nuremberg 22
Mexico City 21
Tokyo 21
Phoenix 20
Montreal 18
Ningbo 18
North York 18
Nürnberg 17
Chennai 16
Atlanta 15
Belo Horizonte 15
Boardman 15
Charlotte 15
Orem 15
Vienna 15
Bari 14
Boston 14
Hefei 14
Porto Alegre 14
Tampa 14
Amsterdam 13
Brasília 13
Karachi 13
Mumbai 13
Baghdad 12
Denver 12
Haikou 12
Lanzhou 12
Redwood City 12
Romola 12
Stockholm 12
Curitiba 11
Falkenstein 11
Fuzhou 11
Guayaquil 11
Totale 12.008
Salva come PNG Salva come JPEG
Nome #
Mutation analysis by direct and whole exome sequencing in familial and sporadic tooth agenesis 341
Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells 314
Environment and bladder cancer: molecular analysis by interaction networks 305
Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease 262
Analysis of a nanoparticle-enriched fraction of plasma reveals miRNA candidates for Down syndrome pathogenesis 262
Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells. 255
Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma 233
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 228
Functional Role of microRNA-23b-3p in Cancer Biology 217
Transmembrane protein TMEM230, regulator of metalloproteins and motor proteins in gliomas and gliosis 210
RET/PTC-1-driven transformation and pro-invasive phenotype of human thyrocytes depend on MET induction and alpha-catenin nuclear translocation 209
Identifying a panel of genes/proteins/miRNAs modulated by arsenicals in bladder, prostate, kidney cancers 209
Effects of miR-193a and sorafenib on hepatocellular carcinoma cells. 207
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 196
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 191
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 189
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC 188
Biological Function of MicroRNA193a-3p in Health and Disease 186
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 185
De novo 1Mb interstitial deletion of 8p22 in a patient with slight mental retardation and speech delay. 181
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 180
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC. 176
Preparazione di colture primarie di fibroblasti di embrione di pollo . 173
miR103 e miR-107 sono coinvolti nella regolazione dell'espressione di CDK5R1/p35 implicato nella migrazione neuronale. 172
Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC 171
MicroRNAs as Biomarkers of hepatocellular carcinoma and molecular targeted therapeutics with sorafenib 167
microRNAs and human hepatocellular carcinoma 165
Differential expression profiling of long non-coding RNA GAS5 and miR-126-3p in human cancer cells in response to sorafenib 160
LASP1 directly interacts with vimentin and its expression stratifies patients affected by human hepatocellular carcinoma 154
The study of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24 and miR-27a differential expression in HCC. 151
The study of HCC cell specific miRNas reveals one novel human miR and miR-21, miR24 and miR-27a differential expression in HCC 151
RT-PCR detection of fibronectin EDA+ and EDB+ mRNA isoforms: molecular markers for hepatocellular carcinoma 148
Circulating microRNAs as promising non-invasive molecular biomarkers of HCC 148
miR24, MiR 27a e miR193a nell'HCC: potenzialità prognostiche e terapeutiche. 144
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 144
In vitro c-met inhibition by antisense RNA and plasmid -based RNAi down modulates migration and invasion of hepatocellular carcinoma cells. 142
The analysis of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24, and miR-27a differential expression in cirrhotic/non- cirrhotic HCC. 141
Molecular characterization of LASP-1 expression reveals vimentin as its new partner in human hepatocellular carcinoma cells. 141
Does miR-338, a putative negative regulator of the facilitative glucose transporter 10 (GLUT10), play a role in arterial tortuosity syndrome? 139
Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy 138
MicroRNA 193a negatively regulates urokinase and in combination with sorafenib impairs the aggressive properties of HCC cells 137
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 132
Characterization of a 13 aminoacid human fibronectin peptide induce matrix assembly and inhibiting migration and invasion in tumor cells 131
A rapid and highly sensitive solid phase enzyme immunoassay specific for human fibronectin using a characterized monoclonal antibody 131
Antisense u-PA mRNA strategy inhibits the proliferation and invasion of human hepatocellular carcinoma cells. 130
Sequential analysis of multistage hepatocarcinogenesis reveals that miR100 and PLK1 dysregulation is an early event maintained along tumor progression. 130
Transformation-enhancing activity of gelatin binding fragments of fibronectin 128
FUNCTIONAL ROLE OF MICRORNA-23b-3p and MICRORNA-193a-3p IN CELL MIGRATION OF CANCER CELLS 128
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK-1 dysregulation is an early event maintained along tumor progression. 127
Transformation enhancing activity present in the plasma of cancer patients binds to gelatin. 126
The combined use of miR-193a and sorafenib displays in vitro anticancer effects in hepatocellular carcinoma. 125
miRNA Editing: New Insights into the Fast Control of Gene Expression in Health and Disease 125
Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells 124
Determination of plasmatic microRNA levels by ddPCR as peripheral biomarkers for IDH-wild type glioblastomas: a pilot study 124
Matrix assembly induction and cell migration and invasion inhibition by a 13-amino acid fibronectin peptide 123
Gene response of human skin fibroblasts to urokinase- and tissue-type plasminogen activators. 122
"Trasformazione indotta dai virus oncogeni ad RNA. Tecniche di produzione e titolazione del RSV in colture di fibroblasti di embrione di pollo" pp. 27- 34, settembre 1987, in: , CLEUP-Padova, Italia. 122
MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. 121
The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration. 121
Interaction of tissue type plasminogen activator with fibronectin and fibronectin fragments 119
Evidence for preferential proteolytic cleavage of one of the two fibronectin subunits and for immunological localization of a site distinguishing them 118
Identification and molecular characterization of cryptic chromosomal rearrangements in mental retardation patients. 118
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis 118
Inhibition of Rous sarcoma virus-induced transformation by proteins involved in blood coagulation 117
Transformation enhancing activity in plasma of tumor patients: relationship with fibronectin fragments 117
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 115
Germline and somatic c-met mutations in multifocal/bilateral and sporadic papillary renal carcinomas of selected patients. 114
Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts 114
Urokinase and c-met are target of miR-23b in human cells. 114
Characterization and development of miRNA-like shRNA for urokinase targeting in human hepatocellular carcinoma 114
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma. 113
Role of fibronectin degradation products on cellular transformation. 111
miRNAs-Based Molecular Signature for KRAS Mutated and Wild Type Colorectal Cancer: An Explorative Study 109
Urokinase targeting in human hepatocellular carcinoma by shRNAs/miR-23b and proteomic identification of LASP1 as uPA effector. 108
DNA methylation variations in familial female and male breast cancer 108
RNA interference against urokinase in hepatocellular carcinoma xenografts in nude mice. 107
MicroRNA ed Epatocarcinoma: il microRNA-23b media la downmodulazione di urochinasi e c-met e la capacità di migrazione di cellule derivate da HCC 107
Il silenziamento di urochinasi in cellule tumorali epatiche determina la downmodulazione di Lasp-1 106
Studi per lo sviluppo di terapie innovative molecolari per l’epatocarcinoma cellulare: microRNA e sorafenib. 106
Downregulation of urokinase by antisense and RNAi strategies inhibits the proliferation and migration of human hepatocellular carcinoma cells. 105
Androgen receptor mRNA under-expression in poorly differentiated human hepatocellular carcinoma. 105
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 104
Espressione stabile di siRNA per il gene urochinasi nell'epatocarcinoma cellulare 103
Tecniche di conservazione delle cellule mediante congelamento. 103
Tissue-type plasminogen activator but not urokinase exerts transformation enhancing activity 102
MicroRNA-23b downmodulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 102
L'espressione stabile della sequenza antisenso dell'mRNA dell'u-PA inibisce la proliferazione e l'invasione di cellule di epatocarcinoma umano. 100
L'espressione stabile di RNA antisenso e di siRNA per u-PA inibisce la proliferazione , la migrazione e l'invasione di cellule di epatocarcinoma umano. 100
Transformation enhancing factors and fibronectin degradation products as possible tumor markers. 100
La trascrizione in Molecole, cellule e Organismi 100
Endocannabinoid system in inflammatory bowel diseases: mucosal gene expression preliminary data 99
Phosphorylation of human plasminogen activators and plasminogen. 99
Specific downregulation of urokinase by stable expression of antisense u-PA mRNA and u-PA siRNA inhibits proliferation, invasion,and migration of human hepatocellular carcinoma. 99
Conditional interactions of fibronectin: C-reactive protein, sulfated proteoglycans, and malignant transformation. 99
Genes and MiRNAs in mental retardation patients with cryptic chromosome imbalances detected by SNP-based array analysis. 99
Il microRNA-23b media la downmodulazione di urochinasi e met ed inibisce la migrazione di cellule umane derivate da epatocarcinoma cellulare. 98
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 98
Plasmatic microRNA levels by ddPCR as peripheral biomarkers for IDH-wild type glioblastomas: a pilot study 97
MET silencing in human hepatocellular carcinoma: antisense and RNA interference 97
MicroRNA-23b negatively regulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 96
Totale 14.438
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.337
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.337
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.402 0 0 0 0 0 246 95 242 324 203 180 112
2021/20221.186 62 215 56 73 10 41 49 68 67 127 130 288
2022/20231.248 186 64 35 123 119 296 13 104 187 10 48 63
2023/20241.308 95 31 137 75 63 274 83 46 233 53 28 190
2024/20253.527 41 64 66 462 326 306 283 119 442 186 802 430
2025/20263.583 600 850 477 935 626 95 0 0 0 0 0 0
Totale 20.011